Intravitreal, Subretinal, and Suprachoroidal Injections: Evolution of Microneedles for Drug Delivery

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Journal of Ocular Pharmacology and Therapeutics

• Publication date

  2017-12-05

• Fields of study

  Medicine

• Identifiers
  DOI 10.1089/jop.2017.0121PMID 29206556PMCID PMC5963636
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Treatment of retinitis pigmentosa due to MERTK mutations by ocular subretinal injection of adeno-associated virus gene vector: results of a phase I trial

  2016cited by this paper
• Intravitreal injections: A review of pharmacological agents and techniques

  2016cited by this paper
• Safety and durability of effect of contralateral-eye administration of AAV2 gene therapy in patients with childhood-onset blindness caused by RPE65 mutations: a follow-on phase 1 trial.

  2016cited by this paper
• Suprachoroidal Corticosteroid Administration: A Novel Route for Local Treatment of Noninfectious Uveitis

  2016cited by this paper
• Phase 2a Randomized Clinical Trial: Safety and Post Hoc Analysis of Subretinal rAAV.sFLT-1 for Wet Age-related Macular Degeneration

  2016cited by this paper
• Endophthalmitis After Intravitreal Injections

  2016cited by this paper
• Correlation of Optical Coherence Tomography and Autofluorescence in the Outer Retina and Choroid of Patients With Choroideremia

  2016cited by this paper
• The Spectrum of CHM Gene Mutations in Choroideremia and Their Relationship to Clinical Phenotype

  2016cited by this paper
• A Comprehensive Review of Mutations in the MERTK Proto-Oncogene.

  2016cited by this paper
• Benefits of gene therapy for both eyes.

  2016cited by this paper
• Human embryonic stem cell-derived retinal pigment epithelium in patients with age-related macular degeneration and Stargardt's macular dystrophy: follow-up of two open-label phase 1/2 studies.

  2015cited by this paper
• Transplantation of human embryonic stem cell-derived retinal tissue in two primate models of retinal degeneration

  2015cited by this paper
• Improvement and decline in vision with gene therapy in childhood blindness.

  2015cited by this paper
• Spectral sensitivity measurements reveal partial success in restoring missing rod function with gene therapy.

  2015cited by this paper
• Intravitreal Injections and Endophthalmitis

  2015cited by this paper
• Gene therapy with recombinant adeno-associated vectors for neovascular age-related macular degeneration: 1 year follow-up of a phase 1 randomised clinical trial.

  2015cited by this paper
• Multimodal assessment of choroideremia patients defines pre-treatment characteristics

  2015cited by this paper
• Endophthalmitis After Intravitreal Injections: Incidence, Presentation, Management, and Visual Outcome.

  2015cited by this paper
• Endophthalmitis After Intravitreal Injections: Incidence, Presentation, Management, and Visual Outcome.

  2015cited by this paper
• Long-term effect of gene therapy on Leber's congenital amaurosis.

  2015cited by this paper
• Endophthalmitis After Intravitreal Injections: Incidence, Presentation, Management, and Visual Outcome.

  2015cited by this paper
• In Vivo and In vitro Force Testing of a New Guarded Injection Device

  2015cited by this paper
• INTRAVITREAL INJECTION TECHNIQUE AND MONITORING: Updated Guidelines of an Expert Panel

  2014cited by this paper
• Particle‐Stabilized Emulsion Droplets for Gravity‐Mediated Targeting in the Posterior Segment of the Eye

  2014cited by this paper
• Pseudo-fovea formation after gene therapy for RPE65-LCA.

  2014cited by this paper
• Treatment of acute posterior uveitis in a porcine model by injection of triamcinolone acetonide into the suprachoroidal space using microneedles.

  2013cited by this paper
• Three-year follow-up after unilateral subretinal delivery of adeno-associated virus in patients with Leber congenital Amaurosis type 2.

  2013cited by this paper
• Comparing the Effects of Three Different Intravitreal Injection Techniques on Vitreous Reflux and Intraocular Pressure

  2013cited by this paper
• Intravitreal injections: a review of the evidence for best practice

  2013cited by this paper
• Faculty Opinions recommendation of Embryonic stem cell trials for macular degeneration: a preliminary report.

  2012cited by this paper
• Microneedles for drug and vaccine delivery.

  2012cited by this paper
• Embryonic stem cell trials for macular degeneration: a preliminary report.

  2012cited by this paper
• Pupillometric analysis for assessment of gene therapy in Leber Congenital Amaurosis patients

  2012cited by this paper
• Safety of Submacular Suprachoroidal Drug Administration via a Microcatheter: Retrospective Analysis of European Treatment Results

  2012influential reference
• AAV2 Gene Therapy Readministration in Three Adults with Congenital Blindness

  2012cited by this paper
• Models of the cutting edge geometry of medical needles with applications to needle design

  2012cited by this paper
• Targeted administration into the suprachoroidal space using a microneedle for drug delivery to the posterior segment of the eye.

  2012cited by this paper
• Incidence of endophthalmitis and use of antibiotic prophylaxis after intravitreal injections.

  2012cited by this paper
• The human visual cortex responds to gene therapy-mediated recovery of retinal function.

  2011cited by this paper
• Preclinical safety evaluation of subretinal AAV2.sFlt-1 in non-human primates

  2011cited by this paper
• Effect of Needle Type and Injection Technique on Pain Level and Vitreal Reflux in Intravitreal Injection

  2011cited by this paper
• Endophthalmitis after intravitreal injections: should the use of face masks be the standard of care?

  2011cited by this paper
• REDUCING ORAL FLORA CONTAMINATION OF INTRAVITREAL INJECTIONS WITH FACE MASK OR SILENCE

  2011cited by this paper
• Bacterial dispersal associated with speech in the setting of intravitreous injections.

  2011cited by this paper
• Dosage Thresholds for AAV2 and AAV8 Photoreceptor Gene Therapy in Monkey

  2011cited by this paper
• Targeted Drug Delivery to the Eye Enabled by Microneedles

  2011cited by this paper
• EXPERIMENTAL MODEL OF INTRAVITREAL INJECTION TECHNIQUES

  2010cited by this paper
• Suprachoroidal Drug Delivery to the Back of the Eye Using Hollow Microneedles

  2010cited by this paper
• Treatment possibilities for retinitis pigmentosa.

  2010cited by this paper
• Rapid expansion of intravitreal drug injection procedures, 2000 to 2008: a population-based analysis.

  2010cited by this paper
• Age-dependent effects of RPE65 gene therapy for Leber's congenital amaurosis: a phase 1 dose-escalation trial.

  2009cited by this paper
• Gene Therapy for Leber's Congenital Amaurosis is Safe and Effective Through 1.5 Years After Vector Administration

  2009cited by this paper
• Risk of endophthalmitis after intravitreal drug injection when topical antibiotics are not required: the diabetic retinopathy clinical research network laser-ranibizumab-triamcinolone clinical trials.

  2009cited by this paper
• Vision 1 year after gene therapy for Leber's congenital amaurosis.

  2009cited by this paper
• Intrascleral Drug Delivery to the Eye Using Hollow Microneedles

  2009cited by this paper
• Human RPE65 Gene Therapy for Leber Congenital Amaurosis: Persistence of Early Visual Improvements and Safety at 1 Year

  2009cited by this paper
• Subretinal transplantation of forebrain progenitor cells in nonhuman primates: survival and intact retinal function.

  2009cited by this paper
• Endophthalmitis after intravitreal injections

  2009cited by this paper
• AAV retinal transduction in a large animal model species: Comparison of a self-complementary AAV2/5 with a single-stranded AAV2/5 vector

  2009cited by this paper
• Subretinal injection of preservative-free triamcinolone acetonide and supernatant vehicle in rabbits: an electron microscopy study

  2008cited by this paper
• Safety and efficacy of gene transfer for Leber's congenital amaurosis.

  2008cited by this paper
• Treatment of Leber Congenital Amaurosis Due to RPE65 Mutations by Ocular Subretinal Injection of Adeno-Associated Virus Gene Vector: Short-Term Results of a Phase I Trial

  2008cited by this paper
• Human gene therapy for RPE65 isomerase deficiency activates the retinoid cycle of vision but with slow rod kinetics

  2008cited by this paper
• Effect of gene therapy on visual function in Leber's congenital amaurosis.

  2008cited by this paper
• Cannulation of the suprachoroidal space: a novel drug delivery methodology to the posterior segment.

  2006cited by this paper
• Safety of recombinant adeno-associated virus type 2-RPE65 vector delivered by ocular subretinal injection.

  2006cited by this paper
• Safety in Nonhuman Primates of Ocular AAV2-RPE65, a Candidate Treatment for Blindness in Leber Congenital Amaurosis

  2006cited by this paper
• The history of peripheral intravenous catheters: how little plastic tubes revolutionized medicine.

  2005cited by this paper
• Microfabricated drug delivery devices.

  2005cited by this paper
• Long-term restoration of rod and cone vision by single dose rAAV-mediated gene transfer to the retina in a canine model of childhood blindness.

  2005cited by this paper
• Periocular routes for retinal drug delivery

  2004cited by this paper
• EVOLVING GUIDELINES FOR INTRAVITREOUS INJECTIONS

  2004cited by this paper
• Evaluation of a novel biomaterial in the suprachoroidal space of the rabbit eye.

  2002cited by this paper
• Posterior segment approach for subretinal transplantation or injection in the canine model.

  2001cited by this paper
• Gene therapy restores vision in a canine model of childhood blindness

  2001cited by this paper
• Posterior Segment Approach for Subretinal Transplantation or Injection in the Canine Model

  2001cited by this paper
• Stable transgene expression in rod photoreceptors after recombinant adeno-associated virus-mediated gene transfer to monkey retina.

  1999cited by this paper
• Pain and mechanical injury of human skin following needle insertions

  1999cited by this paper
• Comparison of external and internal approaches for transplantation of autologous retinal pigment epithelium.

  1992influential reference
• A new procedure for multiple intraretinal transplantation into mammalian eyes.

  1992cited by this paper
• Transplantation of retinal pigment epithelium using a pars plana approach

  1989cited by this paper
• Transplantation of cultured rabbit retinal epithelium to rabbit retina using a closed-eye method.

  1987cited by this paper
• Über die Behandlung der Netzhautablösung durch operative Entleerung der subretinalen Flüssigkeit und Einspritzung von Luft in den Glaskörper

  1911cited by this paper

• Advances in microneedle Technology for Treatment of retinal degenerative diseases: a narrative review

  2026cites this paper
• Real-Time 3D Needle Guidance Using Dynamic Spiral OCT Scanning and Shape-Driven Pose Extraction in Retinal Interventions

  2026cites this paper
• Real-world safety of voretigene neparvovec: a disproportionality analysis for signal detection using the FAERS database.

  2026cites this paper
• Targeting AKT via SC79 for Photoreceptor Preservation in Retinitis Pigmentosa Mouse Models

  2026cites this paper
• Interspecies scaling of suprachoroidal drug delivery using ocular geometry and drug physicochemical properties

  2026cites this paper
• Nanomaterial-Based Anti-Angiogenic Gene Therapy for Retinal Neovascular Diseases: Mechanistic Insights and Preclinical Advances

  2025cites this paper
• An ingenious suprachoroidal injector based on the resistance feedback theory for treatment of macular edema: A short-term pilot study

  2025cites this paper
• Back of the Eye Drug Delivery: Advances, Challenges, and Emerging Opportunities for Transformative Therapies

  2025cites this paper
• Tropism and Retinal Transduction Efficiency of Adeno-Associated Virus Serotypes in Mice

  2025cites this paper
• Micro and nanoneedles for transdermal delivery of insulin

  2025cites this paper
• An Engineered Intravitreal Injection Retinal-Pigment-Epithelium-Tropic Adeno-Associated Virus Vector Expressing a Bispecific Antibody Binding VEGF-A and ANG-2 Rescues Neovascular Age-Related Macular Degeneration in Animal Models and Patients

  2025cites this paper
• Ocular Drug Delivery: Emerging Approaches and Advances

  2025cites this paper
• Optogenetic therapy for retinal degenerative diseases: A review

  2025cites this paper
• Intravitreally Injected Plasmonic Nanorods Activate Bipolar Cells with Patterned Near-Infrared Laser Projection.

  2025cites this paper
• Comparison of different topical anesthetic methods for intravitreal injections: a randomized crossover study

  2025cites this paper
• Advanced Drug Delivery Systems for Age-Related Macular Degeneration Treatment: Latest Trends and Future Prospects.

  2025cites this paper
• Nrf2 Activated by PD-MSCs Attenuates Oxidative Stress in a Hydrogen Peroxide-Injured Retinal Pigment Epithelial Cell Line

  2025cites this paper
• Applications of Modern Cell Therapies: The Latest Data in Ophthalmology

  2025cites this paper
• Targeting the Eye: RNA-Based Therapies, Interferences, and Delivery Strategies

  2025cites this paper
• A New Generation of Gene Therapies as the Future of Wet AMD Treatment

  2024cites this paper
• Mitochondrial transplantation: a promising strategy for the treatment of retinal degenerative diseases

  2024cites this paper
• Ocular and Plasma Pharmacokinetics of Sitagliptin Eye Drops: Preclinical Data

  2024cites this paper
• Preclinical evaluation of NG101, a potential AAV gene therapy for wet age-related macular degeneration

  2024cites this paper
• Subretinal Recombinant Human Tissue Plasminogen Activator Injection Using a 41G Needle for the Management of Submacular Hemorrhages: A Case Report

  2024cites this paper
• Retinal Penetrating Adeno-Associated Virus

  2024cites this paper
• Effectiveness of Suprachoroidal Injection of Triamcinolone Acetonide in Diabetic Macular Edema Following Pars Plana Vitrectomy Using a Modified Custom Microneedle

  2024cites this paper
• Application of Quality by Design in the Development of Hydrogen Sulfide Donor Loaded Polymeric Microparticles

  2024influential citation
• Downregulation of rhodopsin is an effective therapeutic strategy in ameliorating peripherin-2-associated inherited retinal disorders

  2024cites this paper
• BIOMECHANICAL CONSIDERATIONS FOR OPTIMISING SUBRETINAL INJECTIONS.

  2024cites this paper
• Optimization of stereolithographic 3D printing of microneedle micro-molds for ocular drug delivery.

  2024cites this paper
• Feasibility of Direct Vitrectomy-Sparing Subretinal Injection for Gene Delivery in Large Animals

  2024cites this paper
• Polymeric microneedles for the eye: An overview of advances and ocular applications for minimally invasive drug delivery.

  2024cites this paper
• Intraocular nano-microscale drug delivery systems for glaucoma treatment: design strategies and recent progress

  2023cites this paper
• Subretinal recombinant human tissue plasminogen activator injection using a 41G needle for the management of submacular hemorrhages: a 3-case report.

  2023cites this paper
• Recent advances and prospects for lipid-based nanoparticles as drug carriers in the treatment of human retinal diseases.

  2023cites this paper
• Vitreoretinal disease: a critical review on current technological perspectives and innovative drug-delivery strategies.

  2023cites this paper
• Safety and Efficacy of Suprachorodial Injection of Triamcinolone Acetonide: Review of a Novel Treatment

  2023cites this paper
• Intravitreal Administration of Retinal Organoids-Derived Exosomes Alleviates Photoreceptor Degeneration in Royal College of Surgeons Rats by Targeting the Mitogen-Activated Protein Kinase Pathway

  2023cites this paper
• Thermo-responsive Diels-Alder stabilized hydrogels for ocular drug delivery of a corticosteroid and an anti-VEGF fab fragment.

  2023cites this paper
• Discovery and Potential Utility of a Novel Non-Invasive Ocular Delivery Platform

  2023cites this paper
• A novel capsid-XL32-derived adeno-associated virus serotype prompts retinal tropism and ameliorates choroidal neovascularization.

  2023cites this paper
• Development of uniform fenofibrate-loaded biodegradable microparticle by membrane emulsification.

  2023cites this paper
• Protein and polypeptide mediated delivery to the eye.

  2022cites this paper
• Tropism of the Novel AAVBR1 Capsid Following Subretinal Delivery

  2022cites this paper
• Formulation and Evaluation of Polymer‐Based Nanoparticles for Intravitreal Gene‐Delivery Applications

  2022cites this paper
• Microneedle-based ocular drug delivery systems – recent advances and challenges

  2022cites this paper
• Stem cell therapy in retinal diseases

  2022cites this paper
• Self‐Plugging Microneedle (SPM) for Intravitreal Drug Delivery

  2022cites this paper
• Microneedle-assisted drug delivery to the eye

  2022cites this paper
• A simple technique for suprachoroidal space injection of triamcinolone acetonide in treatment of macular edema.

  2022cites this paper
• New pathways for drug and gene delivery to the eye: a mathematical model

  2022cites this paper
• Ophthalmic dosage forms for drug delivery to posterior segment

  2022cites this paper
• Development and ex-vivo validation of 36G polyimide cannulas integrating a guiding miniaturized OCT probe for robotic assisted subretinal injections.

  2022cites this paper
• Controlled release of triamcinolone from an episcleral micro film delivery system for open-globe eye injuries and proliferative vitreoretinopathy.

  2021cites this paper
• Container Closure and Delivery Considerations for Intravitreal Drug Administration

  2021cites this paper
• Peptidomimetics Therapeutics for Retinal Disease

  2021cites this paper
• Novel Needle for Intravitreal Drug Delivery: Comparative Study of Needle Tip Aspirates, Injection Stream and Penetration Forces

  2021cites this paper
• Biomechanics of suprachoroidal drug delivery: From benchtop to clinical investigation in ocular therapies

  2021cites this paper
• Micro/nanodevices for assessment and treatment in stomatology and ophthalmology

  2021cites this paper
• OPTH_A_297139 723..734

  2021cites this paper
• Intraocular Injectable Dosage Form Development: Key Components and Critical Quality Attributes

  2021cites this paper
• Ocular Suspension and Nanosuspension Products: Formulation Development Considerations

  2021cites this paper
• Safety and Efficacy of Suprachoroidal Injection of Triamcinolone in Treating Macular Edema Secondary to Noninfectious Uveitis

  2021cites this paper
• Microneedle scleral patch for minimally invasive delivery of triamcinolone to the posterior segment of eye.

  2021cites this paper
• Suprachoroidal Delivery of Subretinal Gene and Cell Therapy

  2021cites this paper
• Suprachoroidal Drug Delivery

  2021cites this paper
• Non-invasive monitoring of suprachoroidal, subretinal, and intravitreal implants using confocal scanning laser ophthalmoscope (cSLO) and optical coherence tomography (OCT).

  2021cites this paper
• Administration of Ocular Gene Therapy

  2021cites this paper
• Evaluation of a Novel Prefilled Syringe Concept for Ophthalmic Applications: A Formative Human Factors Study

  2021cites this paper
• Intravitreous delivery of melatonin affects the retinal neuron survival and visual signal transmission: in vivo and ex vivo study

  2020cites this paper
• Intravitreal hydrogels for sustained release of therapeutic proteins.

  2020cites this paper
• Dexamethasone delivery to the ocular posterior segment by sustained-release Laponite formulation

  2020cites this paper
• Noninvasive Monitoring of Choroid-Retina Autofluorescence and Intravitreal Nanoparticle Disposition in Royal College of Surgeon Rats of Different Ages and Retinal Thinning

  2020cites this paper
• Intravitreal Injection of Human Retinal Progenitor Cells for Treatment of Retinal Degeneration

  2020cites this paper
• Pharmacodynamic Evaluation: Ocular Pharmacology

  2020cites this paper
• Monitoring New Long-Lasting Intravitreal Formulation for Glaucoma with Vitreous Images Using Optical Coherence Tomography

  2020cites this paper
• Microneedle Technology: An Insight into Recent Advancements and Future Trends in Drug and Vaccine Delivery

  2020cites this paper
• Extraocular, periocular, and intraocular routes for sustained drug delivery for glaucoma.

  2020cites this paper
• Corticosteroids in ophthalmology: drug delivery innovations, pharmacology, clinical applications, and future perspectives

  2020cites this paper
• Conservative management of retinoblastoma: Challenging orthodoxy without compromising the state of metastatic grace. "Alive, with good vision and no comorbidity".

  2019cites this paper
• Ocular Drug Delivery: Nanotechnology, Physical and Chemical Methods, Vitreous Drug Binding, and Aging Eye.

  2019cites this paper
• A review on recent drug delivery systems for posterior segment of eye.

  2018cites this paper
• Glaucomatous optic neuropathy treatment options: the promise of novel therapeutics, techniques and tools to help preserve vision

  2018cites this paper